Qube Research & Technologies (QRT)
CNTA

Qube Research & Technologies (QRT)’s Centessa Pharmaceuticals CNTA Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio CNTA Stock Details CNTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-628,049
Closed -$24.9M – 3540
2026
Q1 		$24.9M Buy
628,049
+249,309
+66% +$6.38M 0.03% 761
2025
Q4 		$9.47M Buy
+378,740
New +$9.59M 0.01% 1380
2025
Q3 		– Sell
-307,880
Closed -$4.05M – 3616
2025
Q2 		$4.05M Buy
307,880
+278,446
+946% +$3.53M ﹤0.01% 1833
2025
Q1 		$423K Sell
29,434
-77,624
-73% -$1.27M ﹤0.01% 2601
2024
Q4 		$1.79M Buy
107,058
+10,543
+11% +$175K ﹤0.01% 1923
2024
Q3 		$1.54M Buy
96,515
+92,992
+2,640% +$1.14M ﹤0.01% 1867
2024
Q2 		$31.8K Sell
3,523
-5,421
-61% -$51.4K ﹤0.01% 2815
2024
Q1 		$101K Buy
8,944
+7,633
+582% +$72.3K ﹤0.01% 3291
2023
Q4 		$10.4K Buy
1,311
+1,242
+1,800% +$8.33K ﹤0.01% 3602
2023
Q3 		$446 Buy
+69
New +$472 ﹤0.01% 3686

Qube Research & Technologies (QRT)'s CNTA Position: Q2 2026 in Review

Qube Research & Technologies (QRT) sold out of Centessa Pharmaceuticals (CNTA) in Q2 2026, closing a stake of 628,049 shares — an estimated $24.9M sold.

Qube Research & Technologies (QRT) first reported a position in CNTA in Q3 2023 and held it in 10 quarters. The position peaked at $24.9M in Q1 2026. 0 funds tracked by Wall St. Rank hold CNTA as of Q2 2026.

  • Qube Research & Technologies (QRT) reported no remaining Centessa Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 628,049 Centessa Pharmaceuticals shares in Q2 2026, an estimated $24.9M.
  • Qube Research & Technologies (QRT) first reported a position in Centessa Pharmaceuticals in Q3 2023 and held it in 10 quarters.
  • Qube Research & Technologies (QRT)'s Centessa Pharmaceuticals position peaked at $24.9M in Q1 2026.
  • 0 funds tracked by Wall St. Rank held Centessa Pharmaceuticals as of Q2 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.